A report on a longitudinal study of the effects, side effects and interaction of naltrexone in low dose.
This article describes the use of low dose naltrexone (LDN) in a patient population receiving compounded product from Skip's Pharmacy. The study followed this population for 3 years. It describes the results of a patient-centric study that subjectively qualitfies the use of LDN by diagnosis and its effects, the incidences of interactions and interactions.
Dr. Skip Lenz is a Fellow of the American College of Veterinary Pharmacist and The American Society of Consultant Pharmacist. He received his B.Pharm in 1973 from Mass.College of Pharmacy and his Pharm.D. in 1999 from University of Florida. He has studied advanced qualitative analysis at Harvard University and quantitative analysis at Brown University. He has spent his career involved with basic and applied research and development.
The last 15 years were spent in compounding pharmacy. He has lectured extensively locally, state wide, nationally and international on issues of governmental regulations. He lives in Boca Raton, Florida with his wife Claudette.